$15.99 $0.53 per serving
Product analysis
Horny Goat Weed offers a limited cognitive-support angle from ginkgo alongside niacin for normal nutrient needs. Yohimbe can raise anxiety and heart rate, which may work against comfortable concentration.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality33
Several botanical markers are named, but their preparation quality remains uncertain. Niacin and maca lack specific form details, limiting a closer comparison.
Ingredient Transparency70
The listed amounts are clear, but some preparations remain unspecified. The ginkgo components also lack individual proportions.
Value For Money40
The available information does not establish the value of the individual contributions. Neither the ingredient list nor the uncertain comparisons demonstrate good or poor value.
Customer Satisfaction59
Customer ratings are broadly favorable, though satisfaction is less consistent. The very small feedback pool limits confidence in that pattern.
Product Focus58
Ginkgo and niacin provide a limited connection to normal cognitive function. Yohimbe may raise anxiety and heart rate, creating tension with the focus-related purpose.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.53
- Customer rating
- 4.1 · 28 ratings
Goals
Impact
Moderate effect
Impact
Moderate effect
Impact
Moderate effect
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Niacin | 80 mg | |
Horny Goat Weed (Icariin Flavones) | 500 mg | |
Maca 4:1 extract | 250 mg | |
Tribulus Terrestris extract (Furostanol Saponins) | 250 mg | |
Ginkgo biloba extract (Flavone Glycosides, Terpene Lactones) | 120 mg | |
Yohimbe extract (Yohimbine) | 100 mg |
Tribulus (Furostanol Saponins) · 250 mg OverallScore100
Each serving provides 250 mg of Tribulus terrestris Fruit Extract, with 40% saponins. The named form helps clarify what is included. There is no basis here to compare its value.
How this ingredient is rated
Composition and Label Disclosure
There is no separate finding on ingredient quality or absorption.
Composition and Label Disclosure100
The serving contains 250 mg of Tribulus terrestris Fruit Extract with 40% saponins.
Amount and Label Disclosure
The serving contains 250 mg of Tribulus terrestris Fruit Extract with 40% saponins.
Commercial Price and Usability
There is no separate value finding.
Ginkgo (Flavone Glycosides, Terpene Lactones) · 120 mg OverallScore85
A serving states 120 mg of ginkgo leaf extract. The stated composition includes 24% flavone glycosides and 6% terpene lactones. A ginkgolic acid limit isn't available in the information provided. The price covers the whole serving, so a separate value for ginkgo isn't available.
How this ingredient is rated
Composition and Label Disclosure70
The stated composition includes 24% flavone glycosides and 6% terpene lactones. A ginkgolic acid limit isn't available in the information provided.
Marker and Preparation Disclosure
The stated composition includes 24% flavone glycosides and 6% terpene lactones.
Declared Ginkgolic Acid Limit
A ginkgolic acid limit isn't available in the information provided.
Composition and Label Disclosure100
A serving states 120 mg of ginkgo leaf extract.
Individual Preparation Amount Disclosure
A serving states 120 mg of ginkgo leaf extract.
Commercial Price and Usability
No separate price or usability assessment was available for ginkgo.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
- Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
- Ginkgo biloba in the Aging Process: A Narrative Review.